Publications by authors named "Christopher Hvisdas"

Claim this Profile
R
Race and ethnicity, not just insurance, is associated with biologics initiation in asthma and related conditions.
Ayobami Akenroye, Christopher Hvisdas, Jessica Stern, John W Jackson, Margee Louisias

J Allergy Clin Immunol· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characterization of Interchanging Incretin Analogs in Clinical Practice: A Descriptive Report.
Christopher M Hvisdas, Natalie D Goode, Diane H Kim, Michael J Silvey, Jeremy J Flood

Endocr Pract· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Factors Associated With Asthma Biologic Prescribing and Primary Adherence Among Adults in a Large Health System.
Patrick K Gleeson, Knashawn H Morales, Christopher Hvisdas, Anthony F LaCava, Michael O Harhay

J Allergy Clin Immunol Pract· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Boxed Warnings and Off-Label Use of Allergy Medications: Risks, Benefits, and Shared Decision Making.
Justin Greiwe, Richard Honsinger, Christopher Hvisdas, Derek K Chu, David M Lang

J Allergy Clin Immunol Pract· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Addressing disparities in biologic drug development in the United States.
Christopher Hvisdas, Margee Louisias, Tanya M Laidlaw, Ayobami Akenroye

J Allergy Clin Immunol· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Revefenacin, a once-daily, long-acting muscarinic antagonist, for nebulized maintenance therapy in patients with chronic obstructive pulmonary disease.
Christopher Hvisdas

Am J Health Syst Pharm· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cost considerations for clinicians prescribing biologic drugs: Who pays?
Christopher Hvisdas, Patrick K Gleeson, Andrea J Apter

J Allergy Clin Immunol· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Is specialty patient care affected by exclusivity?
Regina Swisher, Natalie Blaine, Christopher Hvisdas

Am J Health Syst Pharm· October 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
US Propofol Drug Shortages: A Review of the Problem and Stakeholder Analysis.
Christopher Hvisdas, Andrea Lordan, Laura T Pizzi, Brandi N Thoma

Am Health Drug Benefits· May 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis